1
Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
Condition(s):Diabetes Mellitus; Hypoglycemic EpisodesLast Updated:March 25, 2016Unknown status
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus; Hypoglycemic EpisodesLast Updated:March 25, 2016Unknown status
Condition(s):Type 2 DiabetesLast Updated:December 17, 2012Unknown status
Condition(s):Varicose Veins; Vascular DiseasesLast Updated:April 14, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.